What the research found

Researchers examined health records from approximately 1 million U.S. veterans and identified a notable pattern: individuals with both insomnia and obstructive sleep apnea simultaneously showed markedly elevated cardiovascular risk compared to those with either condition alone. This co-occurrence—termed COMISA—emerged as a distinct risk category for high blood pressure and cardiovascular disease.

The mechanism appears to involve disrupted sleep's effect on cardiovascular recovery. Normally, sleep provides the heart and blood vessels with a window for repair and regulatory reset. When sleep is fragmented by frequent arousals (as in insomnia) or breathing interruptions (as in apnea), this nightly recovery cycle is compromised, leaving the cardiovascular system under sustained strain.

The study specifically investigated whether these sleep disorders exert measurable influence early in cardiovascular disease development—not merely as late-stage complications—suggesting that intervention timing matters for prevention.

Why it matters for you

If you're tracking biomarkers like blood pressure or inflammatory markers, sleep disorders warrant equal attention to diet and training variables. COMISA represents a particularly damaging combination that many clinicians still treat as two separate problems rather than an integrated issue. Addressing both simultaneously may yield better outcomes for your cardiovascular metrics than treating either in isolation.

For protocol optimisation, this research contextualises why sleep quality isn't just recovery logistics—it's a fundamental cardiovascular stressor when disrupted. If you're using TRT or other interventions, poor sleep (whether from insomnia or undiagnosed apnea) could be undermining your cardiovascular resilience gains. Screening for both conditions, rather than assuming you have one or the other, becomes relevant for anyone concerned with long-term heart health biomarkers.

Caveats

• Observational analysis of existing medical data; cannot establish causation, only association
• Veteran population may not generalise to broader demographics
• No detail provided on effect size or hazard ratios
• Study identifies the problem; doesn't evaluate specific interventions or their efficacy
• No information on how COMISA was diagnosed or whether diagnostic criteria were standardised across the cohort